ABI
INFI

Adamant Biomedical Investments’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Adamant Biomedical Investments’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$287K Hold
17,000
– – 0.07% 95
2014
Q3 		$228K Buy
+17,000
New +$202K 0.06% 93

Other funds holding INFI

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Adamant Biomedical Investments's INFI Position: Q4 2014 in Review

Adamant Biomedical Investments held its Infinity Pharmaceuticals, Inc. (INFI) position steady in Q4 2014 at 17,000 shares worth $287K. The position accounts for 0.07% of the portfolio, ranked #95.

Adamant Biomedical Investments first reported a position in INFI in Q3 2014 and has held it in 2 quarters since. 143 funds tracked by Wall St. Rank hold INFI as of Q4 2014.

  • Adamant Biomedical Investments held 17,000 shares of Infinity Pharmaceuticals, Inc. worth $287K as of Q4 2014.
  • Adamant Biomedical Investments left its Infinity Pharmaceuticals, Inc. share count unchanged in Q4 2014.
  • Infinity Pharmaceuticals, Inc. made up 0.07% of Adamant Biomedical Investments's portfolio in Q4 2014, its #95 holding.
  • Adamant Biomedical Investments first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2014 and has held it in 2 quarters since.
  • 143 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.